-
CENTRES
Progammes & Centres
Location
12 results found
जोमाने राबवीत असलेल्या लसीकरण कार्यक्रमांद्वारे लस-प्र
A recent paper by the Indian Council of Medical Research puts the popular theories linking the COVID-19 vaccination and the rise in sudden deaths amon
The watered-down version of the initial TRIPS waiver proposal put forth by India and South Africa indicates that the developed nations’ policy is bu
Can Nepal and India move beyond the hurdles of the past by focusing on new avenues of cooperation in BIMSTEC?
The government intends to vaccinate the entire adult population by 31st December, but the decreasing demand for vaccines signals a rough last lap to a
The race to secure COVID-19 vaccines has laid bare the inherent inequalities in access to global healthcare, which adversely affects developing popula
The arrival of vaccines against Covid-19 gives hope in ending the pandemic that has claimed close to 2.84 million lives so far. However, inoculating millions of people all over the world would require the massive production of vaccines, followed by their equitable distribution. An impediment to production and distribution of vaccines is the intellectual property (IP) rights that their developers enjoy. India and South Africa have together propo
.png)
Various vaccine trials across the world are showing highly promising efficacy, and multiple vaccines are getting approved across continents. The global vaccine race has now entered its second phase, where countries try and procure as many doses of Covid-19 vaccines as possible. India has put its faith primarily in the vaccines of Oxford-AstraZeneca and Bharat Biotech-ICMR. It has also secured future stockpiles of Gamaleya and Novavax vaccines thr
